View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AI46 | Publication ID: Fall 2021 |
Title: Defining "Small Number of Animals" for Minor Use Determination; Periodic Reassessment | |
Abstract:
FDA is amending its animal drug regulations in 21 CFR part 516 to update the definition for "small number of animals." The Minor Use and Minor Species Animal Health Act of 2004 provides incentives to animal drug sponsors to encourage the development of drugs intended for use in minor species and for minor uses in the major animal species. The Federal Food, Drug, and Cosmetic Act includes a statutory definition of "minor use" (21 U.S.C. 321(pp)) that relies on the phrase "small number of animals" to characterize such use. In 2009, FDA defined "small number of animals" for each of the seven major animal species (cattle, swine, horses, turkeys, chickens, dogs, and cats). FDA periodically reassesses the "small number of animals" definition to ensure its accuracy. After completing the most recent reassessment, FDA is changing the "small number of animals" definition for certain species. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 21 CFR 516 | |
Legal Authority: 21 U.S.C. 321(pp) 21 U.S.C. 360ccc-2 21 U.S.C. 371(a) |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Margaret Oeller Director, Office of Minor Use and Minor Species Animal Drug Development Department of Health and Human Services Food and Drug Administration HFV-2, Center for Veterinary Medicine, Room N375, MPN-2, HFV-50, 7500 Standish Place, Rockville, MD 20855 Phone:240 402-0566 Email: margaret.oeller@fda.hhs.gov |